Bisphosphonates and breast carcinoma

The skeleton is a common site of breast carcinoma metastasis; 75% of patients with breast carcinoma demonstrate bone metastases at autopsy. The lytic destruction of bone in these patients is due to excessive osteoclastic activity. By reducing osteoclastic activity, bisphosphonates inhibit bone resor...

Full description

Saved in:
Bibliographic Details
Main Author: Allan Lipton
Format: Revisão
Language:English
Published: 1997
Online Access:https://doi.org/10.1002/(sici)1097-0142(19971015)80:8+<1668::aid-cncr17>3.3.co;2-5
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0142%2819971015%2980%3A8%20%3C1668%3A%3AAID-CNCR17%3E3.0.CO%3B2-Y
Tags: Add Tag
No Tags, Be the first to tag this record!